Edgewise Therapeutics, Inc. EWTX Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s investment proceeds?
- Edgewise Therapeutics, Inc. (EWTX) reported investment proceeds of $108.88M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Edgewise Therapeutics, Inc.'s investment proceeds decreased by 28.0% year-over-year, from $151.12M to $108.88M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.